All Press Releases
PILA PHARMA CEO explains potential of “chili receptor” as diabetes therapy
Dr. Dorte Gram, CEO of PILA PHARMA AB, one of Sweden’s youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence’s insights portfolio, about PILA’s history, its novel diabetes technology and why we should keep an eye on its lead asset that will be taking off with clinical studies in the near future. PILA owns…
2016, 03, 30 — Press release / PILA PHARMA Acquires Ario Pharma’s TRPV1Assets
The clinical assessment of a novel diabetes treatment seems within reach for PILA PHARMA with the acquisition of XEN-D0501, a clinical ready and safe TRPV1 antagonist development candidate
2016, 01, 18 — Change in the Board of Directors and Scientific Advisory Board of PILA PHARMA
18 January 2016 The Chairman of Pila Pharma Board of Director, Mogens Vang Rasmussen has decided to resign from his position in PILA PHARMA at the end of 2015 due to an increased workload as co-owner and partner of Vesicon, a newly established company with the ambition to bring new and innovative ultra sound devices to the market. PILA PHARMA…